摘要
血脑屏障在保护中枢神经系统正常功能的同时也阻止了诊断和治疗药物的脑部递送。在新药研发过程中,评价中枢神经系统药物跨血脑屏障转运入脑的能力对于疾病诊疗非常关键。本文对近年来用于中枢神经系统药物入脑效率的主要体内评价方法进行了总结,为用于治疗中枢系统疾病的药物体内研究提供药动学和药效学的方法学依据。
The blood-brain barrier( BBB) frustrates the diagnosis and therapeutic interventions by the same mechanisms that protect the central nervous system( CNS) against intrusive chemicals. It is very important to assess the BBB permeability of drugs for CNS diseases in the stage of drug discovery. In this review,several methods and techniques in vivo for brain targeting assessment are discussed,so as to offer pharmacokinetic and pharmacodynamic evaluation methods to investigate drugs for CNS diseases treatment.
出处
《中国新药杂志》
CAS
CSCD
北大核心
2016年第9期1013-1017,共5页
Chinese Journal of New Drugs
基金
国家自然科学基金(81100977)
2014年度江苏省高等学校大学生创新创业训练计划省级重点项目(201410312008Z)
关键词
中枢神经系统
血脑屏障
药物转运
体内评价
central nervous system
blood-brain barrier
drug transport
in vivo evaluation